Translational drug discovery validation in large animal models enhances toxicity and efficacy predictability in humans and provides critical knowledge for drug development programs. The Solaris quantitative optical molecular imaging system, when combined with PerkinElmer’s fluorescence molecular imaging probes, can bridge molecular imaging research techniques to support potential clinical outcomes. By distinguishing healthy versus diseased tissue in real-time, researchers can more accurately and completely map tumours.
The Solaris system is designed for ambient lighting conditions found in preclinical surgical research suites and can dynamically use a broad and versatile range of fluorescent probes, offering flexibility for translational researchers when targeting diseases. Research applications include drug efficacy, drug safety, measurement of real-time biological therapeutic responses, and advanced molecular-guided surgery applications such as surgical tumour margin determination in live animal models.
PerkinElmer
Print this page